Streetbeat News

DHLGY

Deutsche Post AG

https://www.deutschepost.de/

CEO

Frank Appel

Open

46.00

Mkt cap

54B

Volume

30K

High

47.08

P/E Ratio

16.23

52-wk high

48.00

Low

46.00

Div yield

0.04

52-wk low

33.89

DHL Group Sponsored ADR (DHLGY) is recommended for growth investors due to its strong growth attributes, suggesting potential for exceptional returns.

Portfolio Pulse from

March 07, 2025 | 7:00 pm

Deutsche Post AG (DHLGY) held its Q4 2024 earnings call, discussing financial performance and future outlook. Key participants included executives and analysts from major financial institutions.

Portfolio Pulse from

March 07, 2025 | 12:15 am

Deutsche Post AG (DHLGY) held its Q3 2024 earnings call, discussing financial performance and future outlook. Key participants included executives and analysts from major financial institutions.

Portfolio Pulse from

November 09, 2024 | 6:15 am

Manchester United and DHL have extended their partnership until 2027, launching the 'United For One Goal' campaign to inspire global positive change.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:06 am

India's Competition Commission (CCI) is investigating Deutsche Post (DHL) (OTC:DHLGY), United Parcel Service Inc (NYSE:UPS), and FedEx Corp (NYSE:FDX) for alleged collusion on discounts and tariffs. The probe, which began in October 2022, was triggered by complaints from the Federation of Indian Publishers. If found guilty, the companies could face significant fines based on their profits or revenue. UPS shares closed 0.35% lower at $156.99 on Thursday.

Portfolio Pulse from Shivani Kumaresan

January 05, 2024 | 12:35 pm

Minneapolis Mayor Jacob Frey has signed an executive order deprioritizing criminal prosecution for possession, use, purchase, cultivation and engaging in practices with “entheogenic plants or plant compounds. German company Acid Berlin is selling a reportedly legal LSD prodrug and shipping it through DHL Group to clients based in Berlin. Reunion Neuroscience is on the brink of going private with final court approval. Filament Health gets ready to uplist to NASDAQ in a $210M SPAC deal. Sales of Johnson & Johnson esketamine drug Spravato rose nearly 100% year-over-year. PharmaTher's DMT patch showed positive outcomes, investment toward the clinical stage. Enveric Biosciences unveiled positive results from animal studies of its psilocin prodrug for anxiety. Core One Labs entered a LOI for the first sale of its psychedelic biosynthetic compounds. AdvisorShares Psychedelics ETF opened Monday, July 24, at $1.94, dropping from prior Friday’s closing at $1.99.

Portfolio Pulse from Lara Goldstein

July 24, 2023 | 9:14 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.